NCT05272683View on ClinicalTrials.gov

Drug-drug Interaction Study with GLPG3667 and Itraconazole in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

April 1, 2022

Study Completion Date

April 22, 2022

Conditions

Healthy

Interventions

DRUG

GLPG3667

On day 1 and day 8, participants will receive a single dose

DRUG

Itraconazole

On days 5 to 11, participants will receive itraconazole once daily

Trial Locations (1)

QC H3P 3P1

Altasciences, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galapagos NV

INDUSTRY